Alphabet Inc.: 13F holdings, Q2 2026

Alphabet Inc. reported 28 positions worth $99.08B in its Form 13F for Q2 2026 (vs. $4.02B in Q1 2026), filed 2026-08-06.

Top holdings

TickerCompanyValue% of portfolioSharesvs. Q1 2026
SPCXSpace Exploration Technologies Corp$94.18B95.0%551,189,500new
PLPLANET LABS PBC$1.17B1.2%35,248,893same
ASTSAST SPACEMOBILE INC$794.72M0.8%8,943,486same
CMECME GROUP INC$769.38M0.8%3,484,020same
ARMARM HOLDINGS PLC-ADR$695.24M0.7%1,960,784same
RVMDREVOLUTION MEDICINES INC$551.84M0.6%2,946,619-11%
-FRESHWORKS INC$164.01M0.2%16,206,643same
PBLSPARABILIS MEDICINES INC$134.65M0.1%4,919,498new
-TEMPUS AI INC$89.86M0.1%1,551,102same
GTLBGITLAB INC$83.19M0.1%2,724,712same
-UIPATH INC$76.46M0.1%7,034,337same
LIFEETHOS TECHNOLOGIES INC$65.71M0.1%3,622,604-4%
-PRIME MEDICINE INC$61.12M0.1%16,562,498same
FRVOFERVO ENERGY CO$51.47M0.1%1,760,732new
-PAYPAY CORP$44.78M0.0%3,125,000same
MAZEMAZE THERAPEUTICS INC$41.44M0.0%1,388,583same
RLAYRELAY THERAPEUTICS INC$26.38M0.0%1,410,029-10%
BBOTBRIDGEBIO ONCOLOGY THERAPEUT$21.51M0.0%2,823,126same
OSCROSCAR HEALTH INC$13.75M0.0%481,988same
BEAMBEAM THERAPEUTICS INC$11.04M0.0%321,604same
VERAVERA THERAPEUTICS INC$10.35M0.0%241,264same
SANASANA BIOTECHNOLOGY INC$9.82M0.0%2,812,500same
GLUEMONTE ROSA THERAPEUTICS INC$9.01M0.0%372,474-46%
LYELLYELL IMMUNOPHARMA INC$4.12M0.0%293,256same
FIGFIGMA INC$3.90M0.0%215,582same
-Spero Therapeutics Inc$1.97M0.0%889,979same
HYPRHYPERFINE INC$1.21M0.0%898,720same
AUTLAUTOLUS THERAPEUTICS LTD$1.12M0.0%698,262same

Sold out in Q2 2026

TickerCompanyValue in Q1 2026
TNYATENAYA THERAPEUTICS INC$632K

Every fund's full quarter-over-quarter changes are in the institutional holdings dataset. Source: SEC Form 13F. Not investment advice.